BioSyent (TSXV: RX)
CA$8.45
(-1.2%)
-CA$0.10
Price as of April 18, 2024, 3:31 p.m. ET
BioSyent Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
BioSyent Company Info
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.